SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950116-03-004048
Filing Date
2003-10-14
Accepted
2003-10-14 15:29:51
Documents
1
Period of Report
2003-11-04
Effectiveness Date
2003-10-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A def14-a.txt DEF 14A 106502
  Complete submission text file 0000950116-03-004048.txt   108059
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-25169 | Film No.: 03939221
SIC: 2834 Pharmaceutical Preparations